Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination

SYNAPS Study Group

Research output: Contribution to journalArticle

Abstract

Axon pathfinding and synapse formation are essential processes for nervous system development and function. The assembly of myelinated fibres and nodes of Ranvier is mediated by a number of cell adhesion molecules of the immunoglobulin superfamily including neurofascin, encoded by the NFASC gene, and its alternative isoforms Nfasc186 and Nfasc140 (located in the axonal membrane at the node of Ranvier) and Nfasc155 (a glial component of the paranodal axoglial junction). We identified 10 individuals from six unrelated families, exhibiting a neurodevelopmental disorder characterized with a spectrum of central (intellectual disability, developmental delay, motor impairment, speech difficulties) and peripheral (early onset demyelinating neuropathy) neurological involvement, who were found by exome or genome sequencing to carry one frameshift and four different homozygous non-synonymous variants in NFASC. Expression studies using immunostaining-based techniques identified absent expression of the Nfasc155 isoform as a consequence of the frameshift variant and a significant reduction of expression was also observed in association with two non-synonymous variants affecting the fibronectin type III domain. Cell aggregation studies revealed a severely impaired Nfasc155-CNTN1/CASPR1 complex interaction as a result of the identified variants. Immunofluorescence staining of myelinated fibres from two affected individuals showed a severe loss of myelinated fibres and abnormalities in the paranodal junction morphology. Our results establish that recessive variants affecting the Nfasc155 isoform can affect the formation of paranodal axoglial junctions at the nodes of Ranvier. The genetic disease caused by biallelic NFASC variants includes neurodevelopmental impairment and a spectrum of central and peripheral demyelination as part of its core clinical phenotype. Our findings support possible overlapping molecular mechanisms of paranodal damage at peripheral nerves in both the immune-mediated and the genetic disease, but the observation of prominent central neurological involvement in NFASC biallelic variant carriers highlights the importance of this gene in human brain development and function.

Original languageEnglish
Pages (from-to)2948-2964
Number of pages17
JournalBrain : a journal of neurology
Volume142
Issue number10
DOIs
Publication statusPublished - Oct 1 2019

Fingerprint

Ranvier's Nodes
Demyelinating Diseases
Protein Isoforms
Inborn Genetic Diseases
Mutation
Exome
Cell Aggregation
Cell Adhesion Molecules
Human Development
Peripheral Nerves
Neuroglia
Intellectual Disability
Synapses
Nervous System
Genes
Fluorescent Antibody Technique
Immunoglobulins
Observation
Genome
Staining and Labeling

Cite this

Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination. / SYNAPS Study Group.

In: Brain : a journal of neurology, Vol. 142, No. 10, 01.10.2019, p. 2948-2964.

Research output: Contribution to journalArticle

@article{c6f9360394924942942e37a7933f158a,
title = "Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination",
abstract = "Axon pathfinding and synapse formation are essential processes for nervous system development and function. The assembly of myelinated fibres and nodes of Ranvier is mediated by a number of cell adhesion molecules of the immunoglobulin superfamily including neurofascin, encoded by the NFASC gene, and its alternative isoforms Nfasc186 and Nfasc140 (located in the axonal membrane at the node of Ranvier) and Nfasc155 (a glial component of the paranodal axoglial junction). We identified 10 individuals from six unrelated families, exhibiting a neurodevelopmental disorder characterized with a spectrum of central (intellectual disability, developmental delay, motor impairment, speech difficulties) and peripheral (early onset demyelinating neuropathy) neurological involvement, who were found by exome or genome sequencing to carry one frameshift and four different homozygous non-synonymous variants in NFASC. Expression studies using immunostaining-based techniques identified absent expression of the Nfasc155 isoform as a consequence of the frameshift variant and a significant reduction of expression was also observed in association with two non-synonymous variants affecting the fibronectin type III domain. Cell aggregation studies revealed a severely impaired Nfasc155-CNTN1/CASPR1 complex interaction as a result of the identified variants. Immunofluorescence staining of myelinated fibres from two affected individuals showed a severe loss of myelinated fibres and abnormalities in the paranodal junction morphology. Our results establish that recessive variants affecting the Nfasc155 isoform can affect the formation of paranodal axoglial junctions at the nodes of Ranvier. The genetic disease caused by biallelic NFASC variants includes neurodevelopmental impairment and a spectrum of central and peripheral demyelination as part of its core clinical phenotype. Our findings support possible overlapping molecular mechanisms of paranodal damage at peripheral nerves in both the immune-mediated and the genetic disease, but the observation of prominent central neurological involvement in NFASC biallelic variant carriers highlights the importance of this gene in human brain development and function.",
author = "{SYNAPS Study Group} and Stephanie Efthymiou and Vincenzo Salpietro and Nancy Malintan and Mallory Poncelet and Yamna Kriouile and Sara Fortuna and {De Zorzi}, Rita and Katelyn Payne and Henderson, {Lindsay B} and Andrea Cortese and Sateesh Maddirevula and Nadia Alhashmi and Sarah Wiethoff and Mina Ryten and Botia, {Juan A} and Vincenzo Provitera and Markus Schuelke and Jana Vandrovcova and Laurence Walsh and Erin Torti and Valeria Iodice and Maryam Najafi and Karimiani, {Ehsan Ghayoor} and Reza Maroofian and Karine Siquier-Pernet and Nathalie Boddaert and {De Lonlay}, Pascale and Vincent Cantagrel and Mhammed Aguennouz and {El Khorassani}, Mohamed and Miriam Schmidts and Alkuraya, {Fowzan S} and Simon Edvardson and Maria Nolano and J{\'e}r{\^o}me Devaux and Henry Houlden",
note = "{\circledC} The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain.",
year = "2019",
month = "10",
day = "1",
doi = "10.1093/brain/awz248",
language = "English",
volume = "142",
pages = "2948--2964",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination

AU - SYNAPS Study Group

AU - Efthymiou, Stephanie

AU - Salpietro, Vincenzo

AU - Malintan, Nancy

AU - Poncelet, Mallory

AU - Kriouile, Yamna

AU - Fortuna, Sara

AU - De Zorzi, Rita

AU - Payne, Katelyn

AU - Henderson, Lindsay B

AU - Cortese, Andrea

AU - Maddirevula, Sateesh

AU - Alhashmi, Nadia

AU - Wiethoff, Sarah

AU - Ryten, Mina

AU - Botia, Juan A

AU - Provitera, Vincenzo

AU - Schuelke, Markus

AU - Vandrovcova, Jana

AU - Walsh, Laurence

AU - Torti, Erin

AU - Iodice, Valeria

AU - Najafi, Maryam

AU - Karimiani, Ehsan Ghayoor

AU - Maroofian, Reza

AU - Siquier-Pernet, Karine

AU - Boddaert, Nathalie

AU - De Lonlay, Pascale

AU - Cantagrel, Vincent

AU - Aguennouz, Mhammed

AU - El Khorassani, Mohamed

AU - Schmidts, Miriam

AU - Alkuraya, Fowzan S

AU - Edvardson, Simon

AU - Nolano, Maria

AU - Devaux, Jérôme

AU - Houlden, Henry

N1 - © The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain.

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Axon pathfinding and synapse formation are essential processes for nervous system development and function. The assembly of myelinated fibres and nodes of Ranvier is mediated by a number of cell adhesion molecules of the immunoglobulin superfamily including neurofascin, encoded by the NFASC gene, and its alternative isoforms Nfasc186 and Nfasc140 (located in the axonal membrane at the node of Ranvier) and Nfasc155 (a glial component of the paranodal axoglial junction). We identified 10 individuals from six unrelated families, exhibiting a neurodevelopmental disorder characterized with a spectrum of central (intellectual disability, developmental delay, motor impairment, speech difficulties) and peripheral (early onset demyelinating neuropathy) neurological involvement, who were found by exome or genome sequencing to carry one frameshift and four different homozygous non-synonymous variants in NFASC. Expression studies using immunostaining-based techniques identified absent expression of the Nfasc155 isoform as a consequence of the frameshift variant and a significant reduction of expression was also observed in association with two non-synonymous variants affecting the fibronectin type III domain. Cell aggregation studies revealed a severely impaired Nfasc155-CNTN1/CASPR1 complex interaction as a result of the identified variants. Immunofluorescence staining of myelinated fibres from two affected individuals showed a severe loss of myelinated fibres and abnormalities in the paranodal junction morphology. Our results establish that recessive variants affecting the Nfasc155 isoform can affect the formation of paranodal axoglial junctions at the nodes of Ranvier. The genetic disease caused by biallelic NFASC variants includes neurodevelopmental impairment and a spectrum of central and peripheral demyelination as part of its core clinical phenotype. Our findings support possible overlapping molecular mechanisms of paranodal damage at peripheral nerves in both the immune-mediated and the genetic disease, but the observation of prominent central neurological involvement in NFASC biallelic variant carriers highlights the importance of this gene in human brain development and function.

AB - Axon pathfinding and synapse formation are essential processes for nervous system development and function. The assembly of myelinated fibres and nodes of Ranvier is mediated by a number of cell adhesion molecules of the immunoglobulin superfamily including neurofascin, encoded by the NFASC gene, and its alternative isoforms Nfasc186 and Nfasc140 (located in the axonal membrane at the node of Ranvier) and Nfasc155 (a glial component of the paranodal axoglial junction). We identified 10 individuals from six unrelated families, exhibiting a neurodevelopmental disorder characterized with a spectrum of central (intellectual disability, developmental delay, motor impairment, speech difficulties) and peripheral (early onset demyelinating neuropathy) neurological involvement, who were found by exome or genome sequencing to carry one frameshift and four different homozygous non-synonymous variants in NFASC. Expression studies using immunostaining-based techniques identified absent expression of the Nfasc155 isoform as a consequence of the frameshift variant and a significant reduction of expression was also observed in association with two non-synonymous variants affecting the fibronectin type III domain. Cell aggregation studies revealed a severely impaired Nfasc155-CNTN1/CASPR1 complex interaction as a result of the identified variants. Immunofluorescence staining of myelinated fibres from two affected individuals showed a severe loss of myelinated fibres and abnormalities in the paranodal junction morphology. Our results establish that recessive variants affecting the Nfasc155 isoform can affect the formation of paranodal axoglial junctions at the nodes of Ranvier. The genetic disease caused by biallelic NFASC variants includes neurodevelopmental impairment and a spectrum of central and peripheral demyelination as part of its core clinical phenotype. Our findings support possible overlapping molecular mechanisms of paranodal damage at peripheral nerves in both the immune-mediated and the genetic disease, but the observation of prominent central neurological involvement in NFASC biallelic variant carriers highlights the importance of this gene in human brain development and function.

U2 - 10.1093/brain/awz248

DO - 10.1093/brain/awz248

M3 - Article

C2 - 31501903

VL - 142

SP - 2948

EP - 2964

JO - Brain

JF - Brain

SN - 0006-8950

IS - 10

ER -